Market closed

Smith & Nephew/SN

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Smith & Nephew

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Ticker

SN

Trading on

LSE

Industry

Health Care Equipment & Supplies

Employees

18,000

Smith & Nephew Metrics

BasicAdvanced
£9.5B
Market cap
40.74
P/E ratio
£0.27
EPS
0.58
Beta
£0.30
Dividend rate
2.79%
Dividend yield
£9.5B
0.58
£12.45
£8.87
2.5M
£0.30
2.509
1.107
62.92
70.221
107.54%
5.25%
4.51%
5.84%
40.744
2.196
1.83
9.65
41.161
2.79%
5.48%
39.77%
3.26%
-17.85%

What the Analysts think about Smith & Nephew

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Smith & Nephew stock.

Smith & Nephew Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Smith & Nephew Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy SN

£

Sign up or log in to buy
Market closed

Upcoming events

Nov
8
Smith & Nephew
Dividend·Payment
$0.144
Per share

FAQs

What’s the current market cap for Smith & Nephew stock?

Smith & Nephew (SN) has a market cap of £9.5B as of October 12, 2024.

What is the P/E ratio for Smith & Nephew stock?

The price to earnings (P/E) ratio for Smith & Nephew (SN) stock is 40.74 as of October 12, 2024.

Does Smith & Nephew stock pay dividends?

Yes, the Smith & Nephew (SN) stock pays dividends to shareholders. As of October 12, 2024, the dividend rate is £0.3038 and the yield is 2.79%. Smith & Nephew has a payout ratio of 107.54% on a trailing twelve-month basis.

When is the next Smith & Nephew dividend payment date?

The next Smith & Nephew (SN) dividend payment is scheduled for November 08, 2024.

What is the beta indicator for Smith & Nephew?

Smith & Nephew (SN) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.